Drugs / sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate
sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00781339 | Oct 2008 → Mar 2010 | bacteriuria | NovaBay Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00781339 ↗ |
| Route | Other | “NVC-422 instilled into the bladder” NCT00781339 ↗ |